News

Filter by:
By year:
Reset
  • Press Release
  • Usher 1B

AAVantgarde to Participate in ARVO 2026, with Presentations at Key Pre-events and New Clinical Data from the LUCE Phase 1/2 Study
  • Press Release
  • Stargardt

AAVantgarde announces completion of recruitment in STELLA natural history study
  • Press Release
  • Other

AAVantgarde appoints Philip Lao as Senior Vice President Business Development
  • Press Release
  • Usher 1B

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa
  • Press Release

AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference